David Durantel
Impact in
- Hepatology top 0.2%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Epidemiology top 0.5%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
- Hepatology 89
- Hepatitis C virus research 86
- Hepatitis Viruses Studies and Epidemiology 16
- Epidemiology 100
- Hepatitis B Virus Studies 89
- Liver Disease Diagnosis and Treatment 31
- Co-authors
- Fabien ZoulimLars Petter JordheimCharles DumontetJulie LuciforaO. HantzSandra Carrouée‐DurantelNicole ZitzmannRaymond A. Dwek
- Journals
- Journal of Hepatology (19 papers)Antiviral Research (14 papers)Hepatology (12 papers)Journal of Virology (6 papers)Journal of General Virology (5 papers)
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
David Durantel
128 papers receiving 6.1k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Hepatology 3.0k
- Epidemiology 3.8k
- Infectious Diseases 1.4k
- Virology 324
- Immunology 803
Countries citing papers authored by David Durantel
This map shows the geographic impact of David Durantel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Durantel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Durantel more than expected).
Fields of papers citing papers by David Durantel
This network shows the impact of papers produced by David Durantel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Durantel. The network helps show where David Durantel may publish in the future.
Co-authors
The 25 scholars most cited alongside David Durantel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 11 | |
| 5 | 2023 | 15 | |
| 6 | Loss of hepatitis D virus infectivity upon farnesyl transferase inhibitor treatment associates with increasing RNA editing rates revealed by a new RT-ddPCR method | 2022 | 12 |
| 7 | 2022 | 3 | |
| 8 | 2021 | 30 | |
| 9 | COVID-19: Discovery, diagnostics and drug development | 2020 | 0 |
| 10 | 2020 | 14 | |
| 11 | 2019 | 1 | |
| 12 | 2018 | 23 | |
| 13 | 2018 | 8 | |
| 14 | 2016 | 56 | |
| 15 | 2015 | 13 | |
| 16 | 2013 | 2 | |
| 17 | 2009 | 5 | |
| 18 | Celgosivir, an alpha-glucosidase I inhibitor for the potential treatment of HCV infection. | 2009 | 80 |
| 19 | 2009 | 29 | |
| 20 | Glucosidase inhibitors induce HCV glycoproteins misfolding, impair viral assembly and release, and reduce the infectivity of residually secreted HCV particles | 2006 | 1 |
About David Durantel
David Durantel is a scholar working on Hepatology, Epidemiology, Virology, Infectious Diseases and Immunology, having authored 131 papers that have together received 6.2k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (89 papers), Hepatitis C virus research (86 papers), Liver Disease Diagnosis and Treatment (31 papers), Hepatitis Viruses Studies and Epidemiology (16 papers), Immunotherapy and Immune Responses (11 papers), interferon and immune responses (10 papers), HIV/AIDS drug development and treatment (9 papers) and Viral gastroenteritis research and epidemiology (8 papers). The work is most often cited by research in Hepatology (3.0k citations), Epidemiology (3.8k citations), Infectious Diseases (1.4k citations), Virology (324 citations) and Immunology (803 citations). David Durantel has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Fabien Zoulim, Lars Petter Jordheim, Charles Dumontet, Julie Lucifora, O. Hantz, Sandra Carrouée‐Durantel, Nicole Zitzmann, Raymond A. Dwek, Massimo Levrero and Barbara Testoni. Their work appears in journals such as Journal of Hepatology, Antiviral Research, Hepatology, Journal of Virology and Journal of General Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.